首页> 外国专利> STRATRIENS 9-ALPHA-SUBSTITUTED AS SELECTIVE EFFECTIVENESS STRATEGES

STRATRIENS 9-ALPHA-SUBSTITUTED AS SELECTIVE EFFECTIVENESS STRATEGES

机译:STRATRIENS 9-ALPHA取代为选择性效能策略

摘要

The invention is related to a new class 9 strategist, replacing the first equation, where R3, R7, R7 ',R13, R16, R17 and R17 'have various meanings as described in the description, while R9 is a linear or separator algebraic electrode, which can be partially or completely halogenated, containing 2 to 6 carbon atoms, an Ethiopian radical or a prop-1-nilo as active pharmaceutical ingredient, In vitro fertilization of rat prostate hormone receptor preparation is closer than in the preparation of mouse uterus receptor, and compared with the uterus, the effect on the ovary in vivo is the best. The invention also involved the preparation of these strategists2. Forms of drug management used for therapeutic purposes and containing new compounds; The invention also uses these compounds to treat diseases and conditions caused by estrogen deficiency.
机译:本发明涉及一种新的9类战略家,它代替了第一个等式,其中R3,R7,R7',R13,R16,R17和R17'具有说明书中所述的各种含义,而R9是线性或分隔代数电极,可以部分或全部卤化,含有2至6个碳原子,埃塞俄比亚基团或prop-1-nilo作为活性药物成分,大鼠前列腺激素受体制剂的体外受精比小鼠子宫受体制剂的离体更近。 ,与子宫相比,体内对卵巢的效果最好。本发明还涉及这些战略家的准备。用于治疗目的并包含新化合物的药物管理形式;本发明还使用这些化合物来治疗由雌激素缺乏引起的疾病和状况。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号